Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Chronic Kidney DiseaseEnd-Stage Renal Disease
Interventions
DRUG

somatropin

Trial Locations (26)

2100

Novo Nordisk Investigational Site, København Ø

3010

Novo Nordisk Investigational Site, Bern

5000

Novo Nordisk Investigational Site, Odense

8200

Novo Nordisk Investigational Site, Århus N

13353

Novo Nordisk Investigational Site, Berlin

44281

Novo Nordisk Investigational Site, Kfar Saba

49100

Novo Nordisk Investigational Site, Petah Tikva

52621

Novo Nordisk Investigational Site, Ramat Gan

58100

Novo Nordisk Investigational Site, Holon

64239

Novo Nordisk Investigational Site, Tel Aviv

69115

Novo Nordisk Investigational Site, Heidelberg

70300

Novo Nordisk Investigational Site, Tzriffin

119074

Novo Nordisk Investigational Site, Singapore

Unknown

Novo Nordisk Investigational Site, Hong Kong

31-501

Novo Nordisk Investigational Site, Krakow

20 - 094

Novo Nordisk Investigational Site, Lublin

05-200

Novo Nordisk Investigational Site, Wołomin

417 17

Novo Nordisk Investigational Site, Gothenburg

B9 5SS

Novo Nordisk Investigational Site, Birmingham

CV2 2DX

Novo Nordisk Investigational Site, Coventry

G11 6NT

Novo Nordisk Investigational Site, Glasgow

L69 3GA

Novo Nordisk Investigational Site, Liverpool

M13 0HZ

Novo Nordisk Investigational Site, Manchester

NE7 7DN

Novo Nordisk Investigational Site, Newcastle

S5 7AU

Novo Nordisk Investigational Site, Sheffield

SA6 6NL

Novo Nordisk Investigational Site, Swansea

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY